HIV-associated nephropathy: Links, risks and management

Laura Palau, Steven Menez, Javier Rodriguez-Sanchez, Tessa Novick, Marco Delsante, Blaithin A. McMahon, Mohamed G. Atta

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Despite the decreased incidence of human immunodeficiency virus (HIV)-associated nephropathy due to the widespread use of combined active antiretroviral therapy, it remains one of the leading causes of end-stage renal disease (ESRD) in HIV-1 seropositive patients. Patients usually present with low CD4 count, high viral load and heavy proteinuria, with the pathologic findings of collapsing focal segmental glomerulosclerosis. Increased susceptibility exists in individuals with African descent, largely due to polymorphism in APOL1 gene. Other clinical risk factors include high viral load and low CD4 count. Advanced kidney disease and nephrotic range proteinuria have been associated with progression to ESRD. Improvement in kidney function has been observed after initiation of combined active antiretroviral therapy. Other treatment options, when clinically indicated, are inhibition of the renin–angiotensin system and corticosteroids. Further routine management approaches for patients with chronic kidney disease should be implemented. In patients with progression to ESRD, kidney transplant should be pursued, provided that viral load control is adequate. Screening for the presence of kidney disease upon detection of HIV-1 seropositivity in high-risk populations is recommended.

Original languageEnglish (US)
Pages (from-to)73-81
Number of pages9
JournalHIV/AIDS - Research and Palliative Care
Volume10
DOIs
StatePublished - Jan 1 2018

Fingerprint

AIDS-Associated Nephropathy
Risk Management
Viral Load
Chronic Kidney Failure
Kidney Diseases
CD4 Lymphocyte Count
Proteinuria
HIV-1
Kidney
Focal Segmental Glomerulosclerosis
Chronic Renal Insufficiency
Adrenal Cortex Hormones
Therapeutics
Transplants
Incidence
Population
Genes

Keywords

  • APOL1 polymorphism
  • ESRD
  • HIV
  • HIVAN
  • Kidney transplant

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Dermatology
  • Infectious Diseases
  • Virology

Cite this

Palau, L., Menez, S., Rodriguez-Sanchez, J., Novick, T., Delsante, M., McMahon, B. A., & Atta, M. G. (2018). HIV-associated nephropathy: Links, risks and management. HIV/AIDS - Research and Palliative Care, 10, 73-81. https://doi.org/10.2147/HIV.S141978

HIV-associated nephropathy : Links, risks and management. / Palau, Laura; Menez, Steven; Rodriguez-Sanchez, Javier; Novick, Tessa; Delsante, Marco; McMahon, Blaithin A.; Atta, Mohamed G.

In: HIV/AIDS - Research and Palliative Care, Vol. 10, 01.01.2018, p. 73-81.

Research output: Contribution to journalReview article

Palau, L, Menez, S, Rodriguez-Sanchez, J, Novick, T, Delsante, M, McMahon, BA & Atta, MG 2018, 'HIV-associated nephropathy: Links, risks and management', HIV/AIDS - Research and Palliative Care, vol. 10, pp. 73-81. https://doi.org/10.2147/HIV.S141978
Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA et al. HIV-associated nephropathy: Links, risks and management. HIV/AIDS - Research and Palliative Care. 2018 Jan 1;10:73-81. https://doi.org/10.2147/HIV.S141978
Palau, Laura ; Menez, Steven ; Rodriguez-Sanchez, Javier ; Novick, Tessa ; Delsante, Marco ; McMahon, Blaithin A. ; Atta, Mohamed G. / HIV-associated nephropathy : Links, risks and management. In: HIV/AIDS - Research and Palliative Care. 2018 ; Vol. 10. pp. 73-81.
@article{f9da30d5d2b24188a54c55fc58692cd6,
title = "HIV-associated nephropathy: Links, risks and management",
abstract = "Despite the decreased incidence of human immunodeficiency virus (HIV)-associated nephropathy due to the widespread use of combined active antiretroviral therapy, it remains one of the leading causes of end-stage renal disease (ESRD) in HIV-1 seropositive patients. Patients usually present with low CD4 count, high viral load and heavy proteinuria, with the pathologic findings of collapsing focal segmental glomerulosclerosis. Increased susceptibility exists in individuals with African descent, largely due to polymorphism in APOL1 gene. Other clinical risk factors include high viral load and low CD4 count. Advanced kidney disease and nephrotic range proteinuria have been associated with progression to ESRD. Improvement in kidney function has been observed after initiation of combined active antiretroviral therapy. Other treatment options, when clinically indicated, are inhibition of the renin–angiotensin system and corticosteroids. Further routine management approaches for patients with chronic kidney disease should be implemented. In patients with progression to ESRD, kidney transplant should be pursued, provided that viral load control is adequate. Screening for the presence of kidney disease upon detection of HIV-1 seropositivity in high-risk populations is recommended.",
keywords = "APOL1 polymorphism, ESRD, HIV, HIVAN, Kidney transplant",
author = "Laura Palau and Steven Menez and Javier Rodriguez-Sanchez and Tessa Novick and Marco Delsante and McMahon, {Blaithin A.} and Atta, {Mohamed G.}",
year = "2018",
month = "1",
day = "1",
doi = "10.2147/HIV.S141978",
language = "English (US)",
volume = "10",
pages = "73--81",
journal = "HIV/AIDS - Research and Palliative Care",
issn = "1179-1373",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - HIV-associated nephropathy

T2 - Links, risks and management

AU - Palau, Laura

AU - Menez, Steven

AU - Rodriguez-Sanchez, Javier

AU - Novick, Tessa

AU - Delsante, Marco

AU - McMahon, Blaithin A.

AU - Atta, Mohamed G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Despite the decreased incidence of human immunodeficiency virus (HIV)-associated nephropathy due to the widespread use of combined active antiretroviral therapy, it remains one of the leading causes of end-stage renal disease (ESRD) in HIV-1 seropositive patients. Patients usually present with low CD4 count, high viral load and heavy proteinuria, with the pathologic findings of collapsing focal segmental glomerulosclerosis. Increased susceptibility exists in individuals with African descent, largely due to polymorphism in APOL1 gene. Other clinical risk factors include high viral load and low CD4 count. Advanced kidney disease and nephrotic range proteinuria have been associated with progression to ESRD. Improvement in kidney function has been observed after initiation of combined active antiretroviral therapy. Other treatment options, when clinically indicated, are inhibition of the renin–angiotensin system and corticosteroids. Further routine management approaches for patients with chronic kidney disease should be implemented. In patients with progression to ESRD, kidney transplant should be pursued, provided that viral load control is adequate. Screening for the presence of kidney disease upon detection of HIV-1 seropositivity in high-risk populations is recommended.

AB - Despite the decreased incidence of human immunodeficiency virus (HIV)-associated nephropathy due to the widespread use of combined active antiretroviral therapy, it remains one of the leading causes of end-stage renal disease (ESRD) in HIV-1 seropositive patients. Patients usually present with low CD4 count, high viral load and heavy proteinuria, with the pathologic findings of collapsing focal segmental glomerulosclerosis. Increased susceptibility exists in individuals with African descent, largely due to polymorphism in APOL1 gene. Other clinical risk factors include high viral load and low CD4 count. Advanced kidney disease and nephrotic range proteinuria have been associated with progression to ESRD. Improvement in kidney function has been observed after initiation of combined active antiretroviral therapy. Other treatment options, when clinically indicated, are inhibition of the renin–angiotensin system and corticosteroids. Further routine management approaches for patients with chronic kidney disease should be implemented. In patients with progression to ESRD, kidney transplant should be pursued, provided that viral load control is adequate. Screening for the presence of kidney disease upon detection of HIV-1 seropositivity in high-risk populations is recommended.

KW - APOL1 polymorphism

KW - ESRD

KW - HIV

KW - HIVAN

KW - Kidney transplant

UR - http://www.scopus.com/inward/record.url?scp=85060232518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060232518&partnerID=8YFLogxK

U2 - 10.2147/HIV.S141978

DO - 10.2147/HIV.S141978

M3 - Review article

AN - SCOPUS:85060232518

VL - 10

SP - 73

EP - 81

JO - HIV/AIDS - Research and Palliative Care

JF - HIV/AIDS - Research and Palliative Care

SN - 1179-1373

ER -